127 related articles for article (PubMed ID: 34666077)
1. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
2. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
4. Cytochrome P450 2D (CYP2D) enzyme dysfunction associated with aging and serotonin deficiency in the brain and liver of female Dark Agouti rats.
Haduch A; Danek PJ; Kuban W; Pukło R; Alenina N; Gołębiowska J; Popik P; Bader M; Daniel WA
Neurochem Int; 2022 Jan; 152():105223. PubMed ID: 34780807
[TBL] [Abstract][Full Text] [Related]
5. Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters.
Anna Haduch A; Bromek E; Daniel WA
Pharmacol Rep; 2013; 65(6):1519-28. PubMed ID: 24553000
[TBL] [Abstract][Full Text] [Related]
6. The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats.
Haduch A; Pukło R; Alenina N; Nikiforuk A; Popik P; Bader M; Daniel WA
Neurochem Int; 2020 Dec; 141():104884. PubMed ID: 33091481
[TBL] [Abstract][Full Text] [Related]
7. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
8. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study.
Bromek E; Haduch A; Daniel WA
Eur J Pharmacol; 2010 Jan; 626(2-3):171-8. PubMed ID: 19818757
[TBL] [Abstract][Full Text] [Related]
9. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
Haduch A; Rysz M; Papp M; Daniel WA
Biochem Pharmacol; 2018 Oct; 156():398-405. PubMed ID: 30195732
[TBL] [Abstract][Full Text] [Related]
10. The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain.
Haduch A; Bromek E; Pukło R; Jastrzębska J; Danek PJ; Daniel WA
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430225
[TBL] [Abstract][Full Text] [Related]
11. The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study.
Haduch A; Bromek E; Kot M; Kamińska K; Gołembiowska K; Daniel WA
J Neurochem; 2015 Apr; 133(1):83-92. PubMed ID: 25581337
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
Daniel WA; Haduch A; Wójcikowski J
Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
14. The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study.
Haduch A; Bromek E; Sadakierska-Chudy A; Wójcikowski J; Daniel WA
Pharmacol Res; 2013 Jan; 67(1):53-9. PubMed ID: 23098818
[TBL] [Abstract][Full Text] [Related]
15. Melatonin Supports CYP2D-Mediated Serotonin Synthesis in the Brain.
Haduch A; Bromek E; Wójcikowski J; Gołembiowska K; Daniel WA
Drug Metab Dispos; 2016 Mar; 44(3):445-52. PubMed ID: 26884482
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 mediates dopamine formation in the brain in vivo.
Bromek E; Haduch A; Gołembiowska K; Daniel WA
J Neurochem; 2011 Sep; 118(5):806-15. PubMed ID: 21651557
[TBL] [Abstract][Full Text] [Related]
17. The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization.
Stocco MR; El-Sherbeni AA; Zhao B; Novalen M; Tyndale RF
Psychopharmacology (Berl); 2021 Jul; 238(7):1791-1804. PubMed ID: 33649968
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms.
Danek PJ; Bromek E; Daniel WA
Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209648
[TBL] [Abstract][Full Text] [Related]
19. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
20. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]